Topical administration of 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol

摘要

PCT No. PCT/JP96/03757 Sec. 371 Date Aug. 27, 1997 Sec. 102(e) Date Aug. 27, 1997 PCT Filed Dec. 24, 1996 PCT Pub. No. WO97/24112 PCT Pub. Date Jul. 10, 1997An external preparation for topical administration which aims at inhibiting rejection reactions at organ or bone marrow transplantation or treating autoimmune diseases or allergic diseases and contains as the active ingredient 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol or a pharmaceutically acceptable acid addition salt thereof.